Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts

dc.contributor.authorEscobar, Enrico
dc.contributor.authorGómez Valenzuela, Fernán
dc.contributor.authorPeñafiel, Cristian
dc.contributor.authorChimenos Küstner, Eduardo
dc.contributor.authorPérez-Tomás, Ricardo
dc.date.accessioned2025-03-18T16:03:38Z
dc.date.available2025-03-18T16:03:38Z
dc.date.issued2023-01-15
dc.date.updated2025-03-18T16:03:38Z
dc.description.abstractBackground: The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related to cell survival and apoptosis. Bcl-2-associated protein X (Bax) and the tumour suppressor protein p53 collectively promote p53-mediated apoptosis. This study aimed to assess the immunohistochemical expression of p53, Bcl-2 and Bax in conventional ameloblastoma (CA), unicystic ameloblastoma (UA) types, and OKC sporadic (OKC-NS/S) and syndromic (OKC-NBSCC). Material and Methods: Paraffinized blocks of CA (n=18), UA (n=15), OKC-NS/S (n=18) and OKC-NBSCC (n=15) fixed in 10% formalin were used. After diagnosis, tissue specimens were stained by immunohistochemistry for p53, Bcl-2 and Bax marker. Stained cells were randomly counted in five high power fields. The data analysis was performed via Shapiro-Wilk test, ANOVA with Tukey’s multiple comparisons or Kruskal-Wallis with Dunn’s multiple comparisons. Statistical significance was defined as p<0.05. Results: We did not observe differences between p53 expression in CA, mural UA (MUA), intraluminal/luminal UA (I/LUA), OKC-NS/S, and OKC-NBSCC (19.69%, 18.74%, 16.76%, 12.35% and 9.04%, respectively). Similar results were recognized for Bax expression in CA, MUA, I/LUA, OKC-NS/S, and OKC-NBSCC (33.72%, 34.95%, 22.94, 21.58% and 20.76%, respectively). However, we recognized significant differences between Bcl-2 expression in OKC-NS/S vs MUA, OKC-NS/S vs I/LUA, OKC-NS/S vs CA, OKC-NBSCC vs MUA, OKCNBSCC vs I/LUA, and I/LUA vs CA. P53, Bcl-2 and Bax levels were higher in mural morphological areas versus intraluminal and luminal morphological areas in UA. Conclusions: There is a tendency for an increased expression of p53, Bcl-2, and Bax proteins in CA, and mural proliferation of UA, compared to lesions with a cystic morphology, which could be associated with a local aggressive behaviour.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec730517
dc.identifier.issn1989-5488
dc.identifier.pmid36911151
dc.identifier.urihttps://hdl.handle.net/2445/219808
dc.language.isoeng
dc.publisherMedicina Oral SL
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.4317/jced.59769
dc.relation.ispartofJournal of Clinical and Experimental Dentistry, 2023, vol. 15, num.2, p. e125-e134
dc.relation.urihttps://doi.org/10.4317/jced.59769
dc.rights(c) Medicina Oral SL, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationCàncer de boca
dc.subject.classificationProteïnes supressores de tumors
dc.subject.classificationApoptosi
dc.subject.otherOral cancer
dc.subject.otherTumor suppressor protein
dc.subject.otherApoptosis
dc.titleAberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
257518.pdf
Mida:
5.69 MB
Format:
Adobe Portable Document Format